APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vaccine (Include COVID-19)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vaccine (Include COVID-19) Industry Growth and Trends Forecast to 2032

Report ID 174044840120 December 2025124 pages

Choose your research edition.

Industry ResearchVaccine (Include COVID-19) Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine (Include COVID-19) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Vaccine (Include COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine (Include COVID-19) Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine (Include COVID-19) Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

According to APO Research, the global Vaccine (Include COVID-19) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vaccine (Include COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vaccine (Include COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine (Include COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Vaccine (Include COVID-19) market include Sanofi, Merck, Pfizer, GSK, AstraZeneca, Zhejiang Pukang, Walvax Biotechnology, Viatris and Sinovac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vaccine (Include COVID-19) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaccine (Include COVID-19) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaccine (Include COVID-19) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaccine (Include COVID-19).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Vaccine (Include COVID-19) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaccine (Include COVID-19) Market by Company

Sanofi

Merck

Pfizer

GSK

AstraZeneca

Zhejiang Pukang

Walvax Biotechnology

Viatris

Sinovac

Sinovac

Serum Institute

Panacea Biotec Ltd

LG Life Sciences

KM Biologics

Hualan Bio

Halfkin Bio-Pharmaceuticals

CSL

Changchun Institute of Biological

Bio-Med

Bharat Biotech

Vaccine (Include COVID-19) Segment by Type

Inactivated Vaccine

Attenuated Vaccine

mRNA

Other

Vaccine (Include COVID-19) Segment by Application

Public

Private

Vaccine (Include COVID-19) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine (Include COVID-19) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine (Include COVID-19) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine (Include COVID-19).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Vaccine (Include COVID-19) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Vaccine (Include COVID-19) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Vaccine (Include COVID-19) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Vaccine (Include COVID-19) Market Share by Region (2021-2026) Table 4. Global Vaccine (Include COVID-19) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Vaccine (Include COVID-19) Market Share by Region (2027-2032) Table 6. Global Vaccine (Include COVID-19) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Vaccine (Include COVID-19) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Vaccine (Include COVID-19) Market Size Share by Type (2021-2026) Table 9. Global Vaccine (Include COVID-19) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Vaccine (Include COVID-19) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Vaccine (Include COVID-19) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Vaccine (Include COVID-19) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Vaccine (Include COVID-19) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Vaccine (Include COVID-19) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Vaccine (Include COVID-19) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Vaccine (Include COVID-19) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Vaccine (Include COVID-19) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Vaccine (Include COVID-19) Market Size Share by Application (2021-2026) Table 24. Global Vaccine (Include COVID-19) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Vaccine (Include COVID-19) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Vaccine (Include COVID-19) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Vaccine (Include COVID-19) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Vaccine (Include COVID-19) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Vaccine (Include COVID-19) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Vaccine (Include COVID-19) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Vaccine (Include COVID-19) Industry Trends Table 37. Vaccine (Include COVID-19) Industry Drivers Table 38. Vaccine (Include COVID-19) Industry Opportunities and Challenges Table 39. Vaccine (Include COVID-19) Industry Restraints Table 40. Global Vaccine (Include COVID-19) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Vaccine (Include COVID-19) Revenue Market Share by Company (2021-2026) Table 42. Global Vaccine (Include COVID-19) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Vaccine (Include COVID-19) Key Company Headquarters & Area Served Table 44. Global Vaccine (Include COVID-19) Company, Product Type & Application Table 45. Global Vaccine (Include COVID-19) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Vaccine (Include COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Vaccine (Include COVID-19) Product Portfolio Table 52. Sanofi Recent Development Table 53. Merck Company Information Table 54. Merck Business Overview Table 55. Merck Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Merck Vaccine (Include COVID-19) Product Portfolio Table 57. Merck Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Pfizer Vaccine (Include COVID-19) Product Portfolio Table 62. Pfizer Recent Development Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GSK Vaccine (Include COVID-19) Product Portfolio Table 67. GSK Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AstraZeneca Vaccine (Include COVID-19) Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Zhejiang Pukang Company Information Table 74. Zhejiang Pukang Business Overview Table 75. Zhejiang Pukang Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Zhejiang Pukang Vaccine (Include COVID-19) Product Portfolio Table 77. Zhejiang Pukang Recent Development Table 78. Walvax Biotechnology Company Information Table 79. Walvax Biotechnology Business Overview Table 80. Walvax Biotechnology Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Walvax Biotechnology Vaccine (Include COVID-19) Product Portfolio Table 82. Walvax Biotechnology Recent Development Table 83. Viatris Company Information Table 84. Viatris Business Overview Table 85. Viatris Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Viatris Vaccine (Include COVID-19) Product Portfolio Table 87. Viatris Recent Development Table 88. Sinovac Company Information Table 89. Sinovac Business Overview Table 90. Sinovac Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sinovac Vaccine (Include COVID-19) Product Portfolio Table 92. Sinovac Recent Development Table 93. Sinovac Company Information Table 94. Sinovac Business Overview Table 95. Sinovac Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sinovac Vaccine (Include COVID-19) Product Portfolio Table 97. Sinovac Recent Development Table 98. Serum Institute Company Information Table 99. Serum Institute Business Overview Table 100. Serum Institute Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Serum Institute Vaccine (Include COVID-19) Product Portfolio Table 102. Serum Institute Recent Development Table 103. Panacea Biotec Ltd Company Information Table 104. Panacea Biotec Ltd Business Overview Table 105. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Portfolio Table 107. Panacea Biotec Ltd Recent Development Table 108. LG Life Sciences Company Information Table 109. LG Life Sciences Business Overview Table 110. LG Life Sciences Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. LG Life Sciences Vaccine (Include COVID-19) Product Portfolio Table 112. LG Life Sciences Recent Development Table 113. KM Biologics Company Information Table 114. KM Biologics Business Overview Table 115. KM Biologics Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. KM Biologics Vaccine (Include COVID-19) Product Portfolio Table 117. KM Biologics Recent Development Table 118. Hualan Bio Company Information Table 119. Hualan Bio Business Overview Table 120. Hualan Bio Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Hualan Bio Vaccine (Include COVID-19) Product Portfolio Table 122. Hualan Bio Recent Development Table 123. Halfkin Bio-Pharmaceuticals Company Information Table 124. Halfkin Bio-Pharmaceuticals Business Overview Table 125. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Portfolio Table 127. Halfkin Bio-Pharmaceuticals Recent Development Table 128. CSL Company Information Table 129. CSL Business Overview Table 130. CSL Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. CSL Vaccine (Include COVID-19) Product Portfolio Table 132. CSL Recent Development Table 133. Changchun Institute of Biological Company Information Table 134. Changchun Institute of Biological Business Overview Table 135. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Changchun Institute of Biological Vaccine (Include COVID-19) Product Portfolio Table 137. Changchun Institute of Biological Recent Development Table 138. Bio-Med Company Information Table 139. Bio-Med Business Overview Table 140. Bio-Med Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Bio-Med Vaccine (Include COVID-19) Product Portfolio Table 142. Bio-Med Recent Development Table 143. Bharat Biotech Company Information Table 144. Bharat Biotech Business Overview Table 145. Bharat Biotech Vaccine (Include COVID-19) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Bharat Biotech Vaccine (Include COVID-19) Product Portfolio Table 147. Bharat Biotech Recent Development Table 148. North America Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Vaccine (Include COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Vaccine (Include COVID-19) Market Share by Country (2021-2026) Table 151. North America Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Vaccine (Include COVID-19) Market Share Forecast by Country (2027-2032) Table 153. Europe Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Vaccine (Include COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Vaccine (Include COVID-19) Market Share by Country (2021-2026) Table 156. Europe Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Vaccine (Include COVID-19) Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Vaccine (Include COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Vaccine (Include COVID-19) Market Share by Country (2021-2026) Table 161. Asia-Pacific Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Vaccine (Include COVID-19) Market Share Forecast by Country (2027-2032) Table 163. Latin America Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Vaccine (Include COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Vaccine (Include COVID-19) Market Share by Country (2021-2026) Table 166. Latin America Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Vaccine (Include COVID-19) Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Vaccine (Include COVID-19) Market Share by Country (2021-2026) Table 171. Middle East & Africa Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Vaccine (Include COVID-19) Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Vaccine (Include COVID-19) Product Image Figure 3. Global Vaccine (Include COVID-19) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Vaccine (Include COVID-19) Market Size (2021-2032) & (US$ Million) Figure 5. Global Vaccine (Include COVID-19) Market Share by Region: 2025 VS 2032 Figure 6. Global Vaccine (Include COVID-19) Market Share by Region (2021-2032) Figure 7. North America Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Inactivated Vaccine Image Figure 13. Global Inactivated Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Attenuated Vaccine Image Figure 15. Global Attenuated Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. mRNA Image Figure 17. Global mRNA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Vaccine (Include COVID-19) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Vaccine (Include COVID-19) Market Share by Type 2025 VS 2032 Figure 22. North America Vaccine (Include COVID-19) Market Size Share by Type (2021-2032) Figure 23. Europe Vaccine (Include COVID-19) Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Vaccine (Include COVID-19) Market Size Share by Type (2021-2032) Figure 25. Latin America Vaccine (Include COVID-19) Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Vaccine (Include COVID-19) Market Size Share by Type (2021-2032) Figure 27. Public Image Figure 28. Global Public Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Private Image Figure 30. Global Private Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Vaccine (Include COVID-19) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Vaccine (Include COVID-19) Market Share by Application 2025 VS 2032 Figure 33. North America Vaccine (Include COVID-19) Market Size Share by Application (2021-2032) Figure 34. Europe Vaccine (Include COVID-19) Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Vaccine (Include COVID-19) Market Size Share by Application (2021-2032) Figure 36. Latin America Vaccine (Include COVID-19) Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Vaccine (Include COVID-19) Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Vaccine (Include COVID-19) Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Vaccine (Include COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Vaccine (Include COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 43. Europe Vaccine (Include COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Vaccine (Include COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 46. Asia-Pacific Vaccine (Include COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Vaccine (Include COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 49. Latin America Vaccine (Include COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Vaccine (Include COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 52. Middle East & Africa Vaccine (Include COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Vaccine (Include COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Vaccine (Include COVID-19) Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Attenuated Vaccine
  • mRNA
  • Other
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • Merck
  • Pfizer
  • GSK
  • AstraZeneca
  • Zhejiang Pukang
  • Walvax Biotechnology
  • Viatris
  • Sinovac
  • Sinovac
  • Serum Institute
  • Panacea Biotec Ltd
  • LG Life Sciences
  • KM Biologics
  • Hualan Bio
  • Halfkin Bio-Pharmaceuticals
  • CSL
  • Changchun Institute of Biological
  • Bio-Med
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Vaccine (Include COVID-19) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Vaccine (Include COVID-19) Market Size by Region (2021-2032)
  5. 1.4.1 Global Vaccine (Include COVID-19) Market Size by Region (2021-2026)
  6. 1.4.2 Global Vaccine (Include COVID-19) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Vaccine (Include COVID-19) Market Size (2021-2032)
  8. 1.5.1 North America Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Vaccine (Include COVID-19) Market Size Growth Rate (2021-2032)
2 Vaccine (Include COVID-19) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Inactivated Vaccine
  3. 2.1.2 Attenuated Vaccine
  4. 2.1.3 mRNA
  5. 2.1.4 Other
  6. 2.2 Global Vaccine (Include COVID-19) Market Size by Type
  7. 2.2.1 Global Vaccine (Include COVID-19) Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Vaccine (Include COVID-19) Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Vaccine (Include COVID-19) Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Vaccine (Include COVID-19) Market Size by Regions
  11. 2.3.1 North America Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Vaccine (Include COVID-19) Market Size Breakdown by Type (2021-2026)
3 Vaccine (Include COVID-19) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Public
  3. 3.1.2 Private
  4. 3.2 Global Vaccine (Include COVID-19) Market Size by Application
  5. 3.2.1 Global Vaccine (Include COVID-19) Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Vaccine (Include COVID-19) Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Vaccine (Include COVID-19) Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Vaccine (Include COVID-19) Market Size by Regions
  9. 3.3.1 North America Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Vaccine (Include COVID-19) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Vaccine (Include COVID-19) Industry Trends
  2. 4.2 Vaccine (Include COVID-19) Industry Drivers
  3. 4.3 Vaccine (Include COVID-19) Industry Opportunities and Challenges
  4. 4.4 Vaccine (Include COVID-19) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Vaccine (Include COVID-19) Revenue (2021-2026)
  2. 5.2 Global Vaccine (Include COVID-19) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Vaccine (Include COVID-19) Key Company Headquarters & Area Served
  4. 5.4 Global Vaccine (Include COVID-19) Company, Product Type & Application
  5. 5.5 Global Vaccine (Include COVID-19) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Vaccine (Include COVID-19) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Vaccine (Include COVID-19) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Vaccine (Include COVID-19) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Vaccine (Include COVID-19) Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Merck Vaccine (Include COVID-19) Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Vaccine (Include COVID-19) Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GSK Vaccine (Include COVID-19) Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Vaccine (Include COVID-19) Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Zhejiang Pukang
  32. 6.6.1 Zhejiang Pukang Company Information
  33. 6.6.2 Zhejiang Pukang Business Overview
  34. 6.6.3 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Zhejiang Pukang Vaccine (Include COVID-19) Product Portfolio
  36. 6.6.5 Zhejiang Pukang Recent Developments
  37. 6.7 Walvax Biotechnology
  38. 6.7.1 Walvax Biotechnology Company Information
  39. 6.7.2 Walvax Biotechnology Business Overview
  40. 6.7.3 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Walvax Biotechnology Vaccine (Include COVID-19) Product Portfolio
  42. 6.7.5 Walvax Biotechnology Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Viatris Vaccine (Include COVID-19) Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Sinovac
  50. 6.9.1 Sinovac Company Information
  51. 6.9.2 Sinovac Business Overview
  52. 6.9.3 Sinovac Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sinovac Vaccine (Include COVID-19) Product Portfolio
  54. 6.9.5 Sinovac Recent Developments
  55. 6.10 Sinovac
  56. 6.10.1 Sinovac Company Information
  57. 6.10.2 Sinovac Business Overview
  58. 6.10.3 Sinovac Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sinovac Vaccine (Include COVID-19) Product Portfolio
  60. 6.10.5 Sinovac Recent Developments
  61. 6.11 Serum Institute
  62. 6.11.1 Serum Institute Company Information
  63. 6.11.2 Serum Institute Business Overview
  64. 6.11.3 Serum Institute Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Serum Institute Vaccine (Include COVID-19) Product Portfolio
  66. 6.11.5 Serum Institute Recent Developments
  67. 6.12 Panacea Biotec Ltd
  68. 6.12.1 Panacea Biotec Ltd Company Information
  69. 6.12.2 Panacea Biotec Ltd Business Overview
  70. 6.12.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Portfolio
  72. 6.12.5 Panacea Biotec Ltd Recent Developments
  73. 6.13 LG Life Sciences
  74. 6.13.1 LG Life Sciences Company Information
  75. 6.13.2 LG Life Sciences Business Overview
  76. 6.13.3 LG Life Sciences Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 LG Life Sciences Vaccine (Include COVID-19) Product Portfolio
  78. 6.13.5 LG Life Sciences Recent Developments
  79. 6.14 KM Biologics
  80. 6.14.1 KM Biologics Company Information
  81. 6.14.2 KM Biologics Business Overview
  82. 6.14.3 KM Biologics Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 KM Biologics Vaccine (Include COVID-19) Product Portfolio
  84. 6.14.5 KM Biologics Recent Developments
  85. 6.15 Hualan Bio
  86. 6.15.1 Hualan Bio Company Information
  87. 6.15.2 Hualan Bio Business Overview
  88. 6.15.3 Hualan Bio Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Hualan Bio Vaccine (Include COVID-19) Product Portfolio
  90. 6.15.5 Hualan Bio Recent Developments
  91. 6.16 Halfkin Bio-Pharmaceuticals
  92. 6.16.1 Halfkin Bio-Pharmaceuticals Company Information
  93. 6.16.2 Halfkin Bio-Pharmaceuticals Business Overview
  94. 6.16.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Portfolio
  96. 6.16.5 Halfkin Bio-Pharmaceuticals Recent Developments
  97. 6.17 CSL
  98. 6.17.1 CSL Company Information
  99. 6.17.2 CSL Business Overview
  100. 6.17.3 CSL Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 CSL Vaccine (Include COVID-19) Product Portfolio
  102. 6.17.5 CSL Recent Developments
  103. 6.18 Changchun Institute of Biological
  104. 6.18.1 Changchun Institute of Biological Company Information
  105. 6.18.2 Changchun Institute of Biological Business Overview
  106. 6.18.3 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Changchun Institute of Biological Vaccine (Include COVID-19) Product Portfolio
  108. 6.18.5 Changchun Institute of Biological Recent Developments
  109. 6.19 Bio-Med
  110. 6.19.1 Bio-Med Company Information
  111. 6.19.2 Bio-Med Business Overview
  112. 6.19.3 Bio-Med Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Bio-Med Vaccine (Include COVID-19) Product Portfolio
  114. 6.19.5 Bio-Med Recent Developments
  115. 6.20 Bharat Biotech
  116. 6.20.1 Bharat Biotech Company Information
  117. 6.20.2 Bharat Biotech Business Overview
  118. 6.20.3 Bharat Biotech Vaccine (Include COVID-19) Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Bharat Biotech Vaccine (Include COVID-19) Product Portfolio
  120. 6.20.5 Bharat Biotech Recent Developments
7 North America
  1. 7.1 North America Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  3. 7.3 North America Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  3. 8.3 Europe Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  3. 10.3 South America Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Vaccine (Include COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Vaccine (Include COVID-19) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Vaccine (Include COVID-19) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst